Neuronetics
STIM | NASDAQ
$1.25
-$0.14 (-10.07%)
At close: Nov 16, 2026, 4:00 PM ET
$1.28
+$0.03 (+2.40%)
After-hours:
Nov 16, 2026, 7:54 PM ET
-10.07%
(1D)No price chart data available for 1D timeframe.
Rating
49.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #294/1021 (Top 29%)
Key Statistics
Market Data
Market Cap $97.16M
1D Range
1.25 1.41
52W Range
1.18 3.30
Valuation (TTM)
PE -3.91
PB 5.19
EV/EBITDA -13.50
Valuation (NTM)
Forward PE N/A
Forward PEG 0.08
Price Target $5.00
Cash Flow
FCF Yield -8.7%
SBC Adj. FCF Yield -15.9%
SBC Impact -84.3%
Margins
Gross Margin 50.7%
Operating Margin -9.4%
FCF Margin -5.3%
Growth (CAGR)
Revenue 3Y | 5Y 32.1% |
23.4%
Dil EPS 3Y | 5Y 57.6% |
25.0%
FCF 3Y | 5Y 34.4% |
21.9%
Returns
ROA -17.5%
ROE -127.9%
ROIC -13.6%
Financial Health
Net Debt
$39.65M
Current Ratio 2.01
Interest Coverage -1.74
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencin...
Sector Healthcare
Industry Medical - Devices
Employees 658
IPO Date Jun 28, 2018
Website www.neurostar.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.02
Beat +77.08%
YoY:
+84.62% REV
$41.96M
Beat +2.97%
YoY:
+12.51%Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+300.00%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove STIM